Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 32Pain, Postoperative 18Neoplasms 15Parkinson Disease 4, Autosomal Dominant Lewy Body 13Lung Neoplasms 12Brain Neoplasms 12Prostatic Neoplasms 9Ovarian Neoplasms 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Stomach Neoplasms 7Depression 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Pain 6Head and Neck Neoplasms 6Thyroid Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leiomyoma 5Agnosia 5Neoplasm Metastasis 4Lymphoma 4Fatigue 4Delirium 4Anxiety Disorders 4Urinary Bladder Neoplasms 3Thromboembolism 3Supratentorial Neoplasms 3Stomatitis 3

Interventions

Propranolol 8Timolol 5Prednisolone 4Prednisone 3Adrenergic beta-Antagonists 3Solutions 2Saline Solution 2Methylprednisolone 2Adrenal Cortex Hormones 2prednisolone phosphate 1Vincristine 1Tomography, Optical Coherence 1Steroids 1Sodium Chloride 1Sirolimus 1Population Groups 1Ointments 1Nadolol 1Mupirocin 1Leuprolide 1Lasers, Semiconductor 1Lasers, Dye 1Imiquimod 1Gels 1Everolimus 1Bleomycin 1Atenolol 1Acebutolol 168Ga-1,4,7-triazacyclononane-N,N',N''-triacetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hemangioma × Saline Solution × Clear all
NCT01685398 2023-09-21

Topical Timolol for Superficial Infantile Hemangioma

Mahidol University

Phase 3 Completed
48 enrolled

Hemangioma

NCT02731287 2018-11-14

Topical Timolol for Infantile Hemangioma in Early Proliferative Phase

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 2 Completed
70 enrolled

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡